Oncology Imaging AI Strategy Pulse 2025-2032: Pathways, Platforms & Playbooks is a global deep-dive on how cancer imaging AI is actually being bought, deployed, and scaled across health systems, OEMs, ...

Despite their growing use in routine clinical practice, guidance on how to set up, evaluate, and ensure the accuracy of these ...

The FDA's approval process was designed for medical devices that stay largely the same after launch. Clinical AI does not operate this way; it is built to evolve.

Taking to the stage at Mobile World Congress, Honor CEO James Li announced Honor’s Alpha Plan, intending to transform the company into an AI Device Ecosystem. That plan starts with “an intelligent ...